managing editor
julia aalbers
Tel: 021 976 4378
Fax: 086 610 3395
e-mail:
Production Editor
SHAUNA GERMISHUIZEN
Tel: 021 785 7178
Fax: 086 628 1197
e-mail:
Editorial Assistant &
Circulation
ELSABÉ BURMEISTER
Tel: 021 976 8129
e-mail:
development editor
GLENDA HARDY
Cell: 071 8196 425
e-mail:
Production
Co-ordinator
WENDY WEGENER
Tel: (021) 976-4378
e-mail:
GAUTENG CONTRIBUTOR
PETER WAGENAAR
Cell 082 413 9954
e-mail :
The
Cardiovascular Journal of Africa
,
incorporating the
Cardiovascular
Journal of South Africa
, is published 10
times a year, the publication date being
the third week of the designated month.
Copyright:
Clinics Cardive Publishing, Pty, Ltd.
Layout:
Martingraphix
Printer:
Durbanville Commercial Printers
All submissions to CVJA are to be
made online via
Electronic submission by means of an
e-mail attachment may be considered
under exceptional circumstances.
Postal address: PO Box 1013,
Durbanville, 7551
Tel/Fax: 021 976 8129
Int.: +27 21 976 8129
e-mail:
Electronic abstracts available on
Pubmed
Audited circulation
Full text articles available on:
or via
co.za; for access codes contact
User ID: cvja8
Password: cvja8
Subscriptions for six issues:
South Africa: R300 (excl VAT)
Other African countries: $30
Overseas: Institutions: R845 ($82)
Individuals: R1 080 ($105)
The views and opinions expressed
in the articles and reviews published
are those of the authors and do not
necessarily reflect those of the editors
of the Journal or its sponsors. In all
clinical instances, medical practitioners
are referred to the product insert
documentation as approved by the
relevant control authorities.
CONTENTS
VOL 23, NO 1. FEBRUARY 2012
40 The clinical value of the Tei index among Nigerians with hypertensive heart failure:
correlation with other conventional indices
AA Akintunde
Review Article
44 The prevalence and heterogeneity of prehypertension: a meta-analysis and meta-
regression of published literature worldwide
X Guo • L Zheng • X Zhang • L Zou • J Li • Z Sun • J Hu • Y Sun
Drug Trends in cardiology
51 Special report from the 2011 International Diabetes Federation
Dr AP Kengne
53 South African 2012 guidelines for hypertension therapy
Therapeutic options in hypertension management: 2012 guidelines from the Southern
African Hypertension Society
J Aalbers
Published online
(Available on
and in Pubmed)
Cardiovascular Topics
e1 Pulse pressure monitoring in hypertensive black Africans
(Interet du suivi de la pression pulsee chez l’hypertendu noir Africain)
C Konin • M Adoh • A Adoubi • A Ekou • J Koffi • JJ N’djessan • A Ahoua
Case Reports
e7 Macro CK in patients with elevated troponin I levels
R Kohli-Kochhar • E Mulwa • G Omuse • P Ojwang
e11 A mysterious case of fatal embolism after the repair
of tetralogy of Fallot: secondary to arrhythmia?
CY Karabay • A Güler • A Kilicgedik • SM Aung •
A Kalayci • G Sahin • IH Tanboga • C Kirma
e13 Giant right atrial myxoma leading to cardiac arrest in
an infant
C Vuran • K Babaoglu • E Ozker • C Ayabakan •
B Saritas • OI Kocyigit • R Turkoz
e16 Coronary muscular bridge mimicking acute stent
thrombosis
CY Karabay • AC Aykan • A Güler • E Alizade •
A Kalayci̇
• R Zehir • C Dunda
e18 Percutaneous closure of patent foramen ovale and
atrial septal aneurysm using the Atriasept
TM
II PFO
occluder: clinical and technical implications
S Brown • D Buys
It's the
shell that
makes
safer.
R
Safety-Coated
R
81mg
The ORIGINAL low dose aspirin
for optimum cardio-protection
Hp
Each tablet contains Aspirin 81mg. Reg.No.: 29/2.7/0767
Pharmafrica (Pty) Ltd, 33 Hulbert Road, New Centre, Johannesburg 2001
Under licence from Goldshield Pharmaceuticals Ltd. U.K.
